134 related articles for article (PubMed ID: 2728381)
1. [Disorders of immune system function and their correction in melanomas with regional metastases].
Labunets IF; Grinevich IuA; Tolstopiatov BA
Vopr Onkol; 1989; 35(4):416-23. PubMed ID: 2728381
[TBL] [Abstract][Full Text] [Related]
2. [Thymopentin in the treatment of cutaneous melanoma].
Trevisan G; Agolzer A
G Ital Dermatol Venereol; 1989 May; 124(5):245-9. PubMed ID: 2695455
[TBL] [Abstract][Full Text] [Related]
3. [The prevention of skin melanoma metastases to the regional lymph nodes].
Korovin SI; Tolstopiatov BA
Vrach Delo; 1990 Apr; (4):80-1. PubMed ID: 2275181
[TBL] [Abstract][Full Text] [Related]
4. [Immunoactive drugs in the combined modality therapy of patients with hypothyroidism].
Epishin AV; Grytsiv VE; Venger EP
Ter Arkh; 1991; 63(2):88-92. PubMed ID: 2048033
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of melanoma of the skin with regional metastases].
Bazhenova AP; Romanova OA; Papliian NP
Khirurgiia (Mosk); 1983 Nov; (11):18-22. PubMed ID: 6664002
[No Abstract] [Full Text] [Related]
7. [Hormonal function of the thymus in malignant melanoma of the skin; the interrelation with immune system disorders].
Grinevich IuA; Labunets IF
Vopr Onkol; 1987; 33(6):46-52. PubMed ID: 3617600
[TBL] [Abstract][Full Text] [Related]
8. [Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer].
Kikot' VA; Dziubko NIa
Vrach Delo; 1989 Jul; (7):46-8. PubMed ID: 2800496
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for melanoma.
Katipamula R; Markovic SN
Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
[TBL] [Abstract][Full Text] [Related]
10. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
11. [Effect of splenin and zymosan on the immune system of patients with a soft tissue sarcoma].
Dziubko NIa; Tolstopiatov BA; Konovalenko VF; Chernenko OD; Redkousova SF
Vrach Delo; 1987 Jul; (7):81-3. PubMed ID: 2442892
[No Abstract] [Full Text] [Related]
12. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
Lesimple T; Neidhard EM; Vignard V; Lefeuvre C; Adamski H; Labarrière N; Carsin A; Monnier D; Collet B; Clapisson G; Birebent B; Philip I; Toujas L; Chokri M; Quillien V
Clin Cancer Res; 2006 Dec; 12(24):7380-8. PubMed ID: 17189411
[TBL] [Abstract][Full Text] [Related]
13. Melanoma in the elderly patient: relevance of the aging immune system.
Hegde UP; Chakraborty N; Kerr P; Grant-Kels JM
Clin Dermatol; 2009; 27(6):537-44. PubMed ID: 19880041
[TBL] [Abstract][Full Text] [Related]
14. [Interrelations of disorders of the endocrine and immune systems of patients with malignant melanoma].
Grinevich IuA
Eksp Onkol; 1988; 10(3):51-4. PubMed ID: 3409834
[TBL] [Abstract][Full Text] [Related]
15. [Use of splenin for the purpose of immunocorrection in patients with seroresistance following syphilis treatment].
Bakhmet'eva TM; Lonshakov IuI; Petrova IV
Vestn Dermatol Venerol; 1988; (10):38-42. PubMed ID: 3223051
[No Abstract] [Full Text] [Related]
16. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
[TBL] [Abstract][Full Text] [Related]
18. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
19. [The intraperitoneal administration of chemical preparations and taktivin in the combined treatment of stomach cancer].
Shchepotin IB; Chernyĭ VA; Grinevich IuA; Kamenets LIa; Osinskiĭ SP
Vrach Delo; 1988 Sep; (9):3-6. PubMed ID: 3212989
[No Abstract] [Full Text] [Related]
20. [The prognosis of patients with level V melanomas of the extremities].
Krüger I; Ghussen F; Groth W
Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
